Acute and Mid-term outcomes of ablation for atrial fibrillation with VISITAG SURPOINT: the Japan MIYABI registry.
Ken OkumuraKoichi InoueMasahiko GoyaHideki OrigasaMakiho YamazakiAkihiko NogamiPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Despite lower anterior wall VS values compared with the CLOSE protocol (≥550), the present study demonstrated comparable efficacy outcomes, indicating that a VS of ≥550 for the anterior wall may not be necessary for Asian patients.
Keyphrases
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- catheter ablation
- heart failure
- liver failure
- prognostic factors
- peritoneal dialysis
- respiratory failure
- type diabetes
- intensive care unit
- left ventricular
- weight loss
- mechanical ventilation
- acute respiratory distress syndrome